ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Atherosclerosis Reduces Anti-Tumor Activity of Liver-Resident Natural Killer Cells

K. Imaoka, M. Ohira, K. Sato, Y. Imaoka, R. Nakano, H. Ohdan

Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Meeting: 2022 American Transplant Congress

Abstract number: 1236

Keywords: Mice, knockout, Natural killer cells, Tumor necrosis factor (TNF), Tumor recurrence

Topic: Basic Science » Basic Science » 08 - Innate Immunity; Chemokines, Cytokines, Complement

Session Information

Session Name: Innate Immunity; Chemokines, Cytokines, Complement

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Abdominal aorta calcification (AAC) is associated with an increased relative risk of coronary events, cerebrovascular events, cardiovascular events, and cardiovascular death. We report that both recipient and donor AAC are independent unfavorable prognostic factors in liver transplantation (hepatectomy). Furthermore, AAC has had a strong relationship with poor overall survival and recurrence-free survival after hepatectomy for hepatocellular carcinoma in our department. However, there has been no study on the relationship between AAC and anti-tumor immune cells in the liver. The aim of this study was to clarify the effect of atherosclerosis on intrahepatic immunity, especially on anti-tumor effects in a mouse model. We focused on the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) activity of liver-resident natural killer (lr-NK) cells.

*Methods: (1) The lr-NK cell activity was evaluated using flow cytometry and a cytotoxicity test and compared between two models: a mouse model of atherosclerosis (ApoE KO mice) and a wild-type mouse model (C57BL/6J) of no atherosclerosis (B6 mice).(2) The lr-NK cell activity after 30% partial hepatectomy (PH) in both models was evaluated using flow cytometry.(3) Liver metastatic growth was evaluated in both models after 2×106 Hepa1-6 cells were injected in the spleens of both strains of mice that underwent 30% PH.

*Results: (1) The proportion of NK cells in the liver decreased in the atherosclerosis model. The TRAIL expression of lr-NK cells was 66.8 ± 6.1% in B6 mice and 42.6 ± 12.7% in ApoE KO mice, as determined using flow cytometry (p<0.01). The cytotoxicity of lr-NK cells against Hepa1-6 cells also significantly decreased in ApoE KO mice compared with B6 mice.(2) The TRAIL expression of lr-NK cells after PH was 42.7 ± 15.2% in B6 mice and 7.0 ± 5.9% in ApoE KO mice, as determined using flow cytometry (p<0.01).(3) Many metastatic lesions were detected in the livers of ApoE KO mice, while no metastatic lesions were detected in those of B6 mice.

*Conclusions: We have demonstrated in a mouse model that calcification of the aorta decreases NK cell activity in the liver. Combined with our findings that AAC in liver transplant donors is associated with activation of lr-NK cells (unpublished data), these data suggest that AAC reduces intrahepatic antitumor activity after liver transplantation.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Imaoka K, Ohira M, Sato K, Imaoka Y, Nakano R, Ohdan H. Atherosclerosis Reduces Anti-Tumor Activity of Liver-Resident Natural Killer Cells [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/atherosclerosis-reduces-anti-tumor-activity-of-liver-resident-natural-killer-cells/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences